Key Points – Q1 earnings weakened as net investment income fell to $0.38 per share from $0.45, while NAV dropped to $18.27 from $19.10.
Management said higher non-accruals, lower base rates, and credit-market volatility were the main pressures. – Crescent raised its non-accruals to 5.7% of debt investments at cost, with five new problem loans concentrated in healthcare
Management said the issues are specific to a small number of portfolio companies rather than broad-based stress in the sector. – The company cut fees and reset its dividend, lowering the base management fee to 1.00%, the incentive fee to 15.0%, and the quarterly base dividend to $0.34 per share. It also approved special dividends in 2026 to work through its spillover balance. Crescent Capital BDC (NASDAQ:CCAP) reported a more difficult first quarter as higher non-accruals, lower base rates and broader credit-market volatility weighed on earnings and net asset value, prompting management to lower fees and reset the company’s base dividend.
Chief Executive Officer Jason Breaux said the quarter unfolded against a backdrop of “elevated geopolitical uncertainty, mixed consumer sentiment, and persistent inflationary pressures,” which contributed to volatility in credit markets. He said private credit is showing “pockets of pressure,” though he cautioned that the broader narrative around the asset class may overstate risk by grouping distinct issues together. “A small number of credit-specific developments within CCAP’s portfolio drove a more challenging quarter,” Breaux said. He added that the issues are concentrated and being actively managed.